Previously submitted to: JMIR Research Protocols (no longer under consideration since Mar 25, 2025)
Date Submitted: Aug 5, 2024
Open Peer Review Period: Aug 10, 2024 - Oct 5, 2024
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Handwriting as an objective tool to support the identification of people with Alzheimer’s disease: suitability of an assessment protocol
ABSTRACT
Background:
Alzheimer’s disease (AD) is the most common of dementia, and has associated cognitive and motor disorders, with consequences on daily activities, including handwriting. Handwriting has been used to study fine motor control or executive functioning in healthy and unhealthy populations. Changes in this skill are present at different stages of the clinical course of Alzheimer’s Disease. Sensorimotor deterioration is observed in handwriting tasks (motion kinematics, such as movement time, speed, and profiles) and brain activity rhythms.
Objective:
We aim to study the suitability of a handwriting assessment protocol to differentiate handwriting characteristics and the associated brain activity in older people with AD and cognitively healthy.
Methods:
Subjects from three organizations (one hospital and two Residential Centers for the Elderly) were recruited. Participants were either cognitively healthy or had clinical diagnoses of minor cognitive impairment or dementia, suggestive of AD. When a direct assessment by a neurologist was not feasible, as in the two nursing homes, participants undertook a comprehensive neuropsychological evaluation that supported the existing diagnoses by clinicians in charge. All participants performed a handwriting assessment with the following instruments: Beery Buktenica Visual-Motor Integration Development Test – 6 and Adult Writing Assessment Battery (HAB). The handwriting tasks were carried out on a Wacom digitizing platform, and the data extraction was done through the MovAlyzeR software. Participants wore an EPOC X helmet during handwriting tasks to assess brain activity.
Results:
The study received funding in May 2023. Data collection was initiated in January 2024. As of April 2024, 21 participants had been enrolled (female: n=17; male, n=3; cognitively healthy: n=9, dementia: n=11). Data collection finished on July 2024. Data analysis and dissemination of findings will be submitted at the beginning of 2025.
Conclusions:
The findings from this research can contribute to a more in-depth knowledge of this subject and potentially support early identification and treatment. Clinical Trial: ClinicalTrials.gov Protocol Identifier: NCT06483438
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.